Domov › Diabetes mellitus 2. typu › South Carolina
Klinické štúdie Diabetes mellitus 2. typu v štáte South Carolina
20 štúdií pre Diabetes mellitus 2. typu hľadá účastníkov v zariadeniach v štáte South Carolina.
Mestá v štáte South Carolina
- North Charleston5 štúdií
- Greenville4 štúdií
- Mount Pleasant3 štúdií
- Myrtle Beach3 štúdií
- Columbia3 štúdií
Oficiálny text štúdie (anglicky)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Monroe Biomedical Research - Charleston, North Charleston
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07783802EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Piedmont Research Partners, LLC, Fort Mill
- Velocity Clinical Research-Gaffney-69046, Gaffney
- Tribe Clinical Research LLC - Greenville, Greenville
- a 1 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- PanAmerican Clinical Research - Bluffton, Bluffton
- Spartanburg Medical Research, Spartanburg
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07754461A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Medical University of South Carolina, Charleston
Prebieha náborVítaní zdravých dobrovoľníkov
Vek 55 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT06112418A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Accellacare - Mt Pleasant, Mt. Pleasant
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07282600Improving the Collaborative Health of Adult Dyads
- University of South Carolina, Columbia
Prebieha náborVítaní zdravých dobrovoľníkov
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT05370014A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Bluffton
- AURORA-2 Clinical Site, Clemson
- AURORA-2 Clinical Site, Columbia
- a 1 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT07743450A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- Monroe Biomedical Research Charleston, North Charleston
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT07340320A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Coastal Carolina Research Center, North Charleston
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT07351058A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Monroe Biomedical Research, LLC, North Charleston
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 11. 9. 2026 · NCT07668388A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Myrtle Beach
- Research Site, North Charleston
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Velocity Clinical Research, Anderson, Anderson
- Accellacare Charleston, Mt. Pleasant
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07296484A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, Gaffney
- Research Site, Greenville
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT07662135AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Piedmont Research Partners, LLC, Fort Mill
- Accellacare US Inc._SC, Mt. Pleasant
- Trial Management Associates, Myrtle Beach
Prebieha náborFáza 3
Vek 45 a viac · Všetky pohlavia · Aktualizované 1. 9. 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Anderson
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 31. 8. 2026 · NCT07662044A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
- Research Site, Gaffney
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT07606066Specimen and Data Collection in South Carolina Medicaid-Enrolled Patients With Type 2 Diabetes (T2D) and Metabolically Healthy Controls
- Clemson Health Clinic at Orangeburg, Orangeburg
- Clemson Health Clinic at Walhalla, Walhalla
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkovUvádza odmenu pre účastníkov
Vek 40 až 70 · Všetky pohlavia · Aktualizované 18. 8. 2026 · NCT07731399A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Prisma Health Pediatric Endocrinology, Columbia
- Prisma Health Midlands, Greenville
Prebieha náborFáza 3
Vek 10 až 17 · Všetky pohlavia · Aktualizované 7. 8. 2026 · NCT06739122A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
- Research Site, Myrtle Beach
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 8. 2026 · NCT07664553CGM for Management of Type 2 Diabetes in Pregnancy
- Prisma Health Greenville Memorial Hospital, Greenville
Prebieha nábor
Vek 18 až 50 · Ženy · Aktualizované 29. 6. 2026 · NCT06628453Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.